Lilly’s breast cancer combo wins approval
Lilly’s breast cancer combo wins approval STAT
Tumors require a blood supply to grow and survive. The blood vessels that nourish tumors can have different characteristics across cancer types and could be connected to patient survival and outcomes. Researchers from Mass General Brigham Cancer Institute, the Broad Institute of MIT and Harvard, and Harvard T.H. Chan…
ASTRO Issues Its First Clinical Guideline on Radiation Therapy for Bladder Cancer The ASCO Post
«Опухоль молчит»: Онколог назвала виды рака, которые долго не дают о себе знать Life.ru
The chemotherapy agent doxorubicin is used successfully to treat a range of cancers but can, as a side effect, damage the heart muscle. Researchers at the Heidelberg Faculty of Medicine at Heidelberg University have now identified the molecular signaling pathway through which doxorubicin causes cardiac injury. They…
Витамин С может улучшить выживаемость при высоком риске развития лейкоза Medvestnik
EVITA clinical trial evaluates oral vitamin C for pre-cancerous blood disorders News-Medical
Understanding and targeting the tumour matrisome Nature
Sana Al Sukhun at COGC 2026: Breast Cancer Priorities Where Resources Are Limited Oncodaily
Росздравнадзор опроверг нехватку противоопухолевого препарата капецитабина moika78.ru
Moderna представляет данные по терапии рака на конгрессе ESMO Investing.com
Imlunestrant Combo Approved for ESR1-Mutated Breast Cancer Medscape
Врач Киевская: колоноскопия после теста FIT поможет предотвратить рак кишечника Дзен
Can vitamin C improve outcomes in people with pre-cancer blood disorders? WebWire
Jack Ady Cancer Centre hosts clinical trial mylethbridgenow.com